Trial intelligence / Profile preview

Efficacy and Safety of Tapentadol (CG5503) for Acute Pain After Bunionectomy

NCT00364247Phase 3Completed

Sponsor
Johnson & Johnson
Primary completion
May 2007
Modality
Small Molecules
01

Overview

A Phase 3 trial of tapentadol in acute pain, sponsored by Johnson & Johnson. Status: completed.

02

Drugs

tapentadol
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT00364247.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00364247.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call